Holger Stark
Holger Stark (Prof. Dr. Dr. h. c.), born on September 15, 1962, is a German pharmacist and a
Professional background
Stark pursued
Scientific research
Stark's academic pursuits have been centered on drug discovery. His research specializes in developing novel synthetic receptor ligands for G protein-coupled receptors, particularly histamine and dopamine receptors, with a focus on achieving high affinity and selectivity. Employing a blend of chemical synthesis, rational drug design, and pharmacological and cell-biological testing, Stark's approach aims to create pharmacological tools like fluorescent ligands, as well as potential new drug candidates for conditions such as Parkinson's disease, Alzheimer's disease, and schizophrenia, with the goal of restoring normal physiological functions.[6] His research interests extend to various other pharmaceutical and medical domains, including NMDA receptor ligands, sphingolipids, enzyme inhibitors (such as monoamine oxidase and cholinesterase), cyclooxygenase, arachidonate-5-lipoxygenase, and ion channels.[1]
Memberships
Stark holds membership in several pharmaceutical and scientific societies and organizations, including the German Pharmaceutical Society (DPhG), where he served as chairman of the Hessen state group from 2004 to 2013. Since 2014, he has chaired the DPhG state group in Rheinland. Additionally, he is affiliated with the German Chemical Society (GdCh), the European Histamine Research Society (EHRS), and the Frankfurt Pharmacy School e.V., an organization he helped establish.[1]
Awards and honours
Source:[1]
- 1992: Joachim Tiburtius Prize (recognition prize) from the State of Berlin for an outstanding dissertation
- 1997/2004: PHOENIX Pharmacy Science Prizes for pharmaceutical chemistry from PHOENIX Pharmahandel AG & Co., Heidelberg and Erlangen
- 2000: Call for pharmaceutical/medicinal chemistry (C3) at Johann Wolfgang Goethe University in Frankfurt am Main (accepted)
- 2005: Call for pharmaceutical chemistry (W3) at the Technical University Carolo-Wilhelmina in Braunschweig (declined)
- 2007: Professor of Pharmaceutical/Medicinal Chemistry (W3) at Johann Wolfgang Goethe University in Frankfurt am Main
- 2008: Appointment to the Chair of Pharmaceutical Chemistry at Leopold Franzens University, Innsbruck/Austria (declined)
- 2008: Hessian University Prize for Excellence in Teaching "Project of a working group or organizational unit" (4th place)
- 2013: Professor of Pharmaceutical and Medicinal Chemistry (W3) at Heinrich Heine University Düsseldorf (accepted)
- 2016: Honorary Doctorate from the University of Niš, Serbia
- 2018: Heinrich Heine University Prize for Excellence in Teaching for "Innovative teaching concept" for the first-semester excursion "Pharmanauts"[7]
References
- ^ a b c d e f g "CV Holger Stark" (PDF). Retrieved 2022-09-14.
- ^ a b "Group leader Univ.-Prof. Dr. Dr. h. c. Holger Stark". Retrieved 2022-09-14.
- ^ "EMA public information Wakix" (PDF).
- ^ "EMA public information Ozawade" (PDF). Retrieved 2022-09-14.
- ^ "HHU Ehrendoktorwürde der Universität Niš für Pharmazeuten Holger Stark". 6 July 2016. Retrieved 2022-09-14.
- ^ "HHU Holger Stark research areas". Retrieved 2022-09-14.
- ^ "HHU Lehrpreis 2018". Retrieved 2022-09-14.
External links
- Holger Stark publications indexed by Google Scholar